(Q28193653)

16

object named as

Harold I Feldman

0 references

Jennifer Gassman

5

object named as

Jennifer J Gassman

0 references

author name string

Bradley S Dixon

1

0 references

Gerald J Beck

2

0 references

Laura M Dember

3

0 references

Thomas A Depner

4

0 references

Tom Greene

6

0 references

Lawrence G Hunsicker

8

0 references

James S Kaufman

9

0 references

Jeffrey H Lawson

10

0 references

Catherine M Meyers

11

0 references

John P Middleton

12

0 references

Milena Radeva

13

0 references

Steve J Schwab

14

0 references

James F Whiting

A prospective evaluation of PTFE graft patency and surveillance techniques in hemodialysis access

15

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

Clinical Trials

0 references

volume

2

0 references

issue

5

0 references

page(s)

400-12

0 references

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Permanent vascular access: a nephrologist's view

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

A(2B) receptors mediate antimitogenesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Dipyridamole inhibits PDGF- and bFGF-induced vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Aspirin enhances platelet-derived growth factor-induced vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Extended-release dipyridamole/aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Theory and validation of access flow measurement by dilution technique during hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

A practical approach to vascular access for hemodialysis and predictors of success.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Vascular access survival among incident hemodialysis patients in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Do we still need dipyridamole?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Effect of dialysis dose and membrane flux in maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Approximately optimal one-parameter boundaries for group sequential trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Vascular access for hemodialysis: 2004 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Associations with predialysis vascular access management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Late creation of vascular access for hemodialysis and increased risk of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

The association of initial hemodialysis access type with mortality outcomes in elderly medicare ESRD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA

DOES ASPIRIN PRECIPITATE MAJOR GASTROINTESTINAL BLEEDING IN PATIENTS ON HÆMODIALYSIS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN110OA